Common use of EFFECTIVE AND BINDING AGREEMENT Clause in Contracts

EFFECTIVE AND BINDING AGREEMENT. A. All terms and conditions of the CIA not modified in this Amendment shall remain in effect for the remainder of the five-year period of compliance obligations that began on the CIA’s Effective Date of July 3, 2017. The Effective Date of this Amendment shall be the date the final signatory signs this Amendment (Amendment Effective Date). B. The undersigned FHS and Xxxxx Xxxxxxxx signatories represent and warrant that they are authorized to execute this Amendment. The undersigned OIG signatories represent that they are signing this Amendment in their official capacities and that they are authorized to execute this Amendment. C. This Amendment may be executed in counterparts, each of which constitutes an original and all of which constitute one and the same Amendment. Facsimiles of signatures shall constitute acceptable, binding signatures for purposes of this Amendment. /Xxxxxx Xxxxxx/ _ 2/19/20 XXXXXX XXXXXX DATE President Foundations Health Solutions, Inc. /Xxxx X. Xxxxxx/_ _ 2/19/20 XXXX X. XXXXXX DATE Counsel for Foundations Health Solutions, Inc. Xxxx Xxxxxxx Xxxxxx Xxxx LLP /Xxxxx Xxxxxxxx/_ _ 2/19/20 XXXXX XXXXXXXX DATE /Xxxx X. Xxxxxx/_ _ 2/19/20 XXXX X. XXXXXX DATE Counsel for Xxxxx Xxxxxxxx Xxxx Xxxxxxx Xxxxxx Xxxx LLP /Xxxx X. Re/ _ 2/28/2020 XXXX X. RE DATE Assistant Inspector General for Legal Affairs Office of Inspector General U.S. Department of Health and Human Services /Xxxxx X. Xxxxx/ 3/2/2020 XXXXX X. XXXXX DATE Senior Counsel Office of Inspector General U.S. Department of Health and Human Services This Appendix contains the requirements relating to the Independent Review Organization (IRO) required by Section III.E of the CIA.

EFFECTIVE AND BINDING AGREEMENT. A. All terms and conditions of the CIA not modified and in this Amendment shall remain in effect for five years after the remainder of the five-year period of compliance obligations that began on the CIA’s Effective Date of July 3, 2017. The Effective Date of this Amendment shall be the date the final signatory signs this Amendment (Amendment CIA Effective Date). B. The undersigned FHS and Xxxxx Xxxxxxxx Xxxxxxx signatories represent and warrant that they are authorized to execute this Amendment. The undersigned OIG signatories represent that they are signing this Amendment in their official capacities and that they are authorized to execute this Amendment. C. This Amendment may be executed in counterparts, each of which constitutes an original and all of which constitute one and the same Amendment. Facsimiles of signatures shall constitute acceptable, binding signatures for purposes of this Amendment. /Xxxxxx Xxxxxx/ _ 2/19/20 XXXXXX XXXXXX DATE /J. Xxxx Xxxx/ 10/29/19 J. XXXX XXXX President Foundations Health Solutionsand Chief Executive Officer Xxxxxxx Regional Medical Center, Inc. /Xxxx DATE /Xxxxxxx X. Xxxxxx/_ _ 2/19/20 XXXX XxXxxx/ 10/29/19 XXXXXXX X. XXXXXX DATE Counsel for Foundations Health SolutionsXxxxxxx Regional Medical Center, Inc. Xxxx Xxxxxxx Xxxxxx Xxxx LLP /Xxxxx Xxxxxxxx/_ _ 2/19/20 XXXXX XXXXXXXX DATE /Xxxx X. Xxxxxx/_ _ 2/19/20 XXXX X. XXXXXX DATE Counsel for Xxxxx Xxxxxxxx Xxxx Xxxxxxx Xxxxxx Xxxx LLP /Xxxx X. Re/ _ 2/28/2020 10/25/2019 XXXX X. RE DATE Assistant Inspector General for Legal Affairs Office of Inspector General U.S. U. S. Department of Health and Human Services /Xxxxx X. Xxxxx/ 3/2/2020 Xxxxxxx/ 10/30/2019 XXXXX X. XXXXX XXXXXXX DATE Senior Counsel Office of Inspector General U.S. U. S. Department of Health and Human Services This Appendix contains the requirements relating to the Claims Review Independent Review Organization (Claims Review IRO) required by Section III.E of the First Amendment to the CIA.

EFFECTIVE AND BINDING AGREEMENT. A. All terms and conditions of the CIA not modified in this Amendment shall remain in effect for the remainder of the five-year period of compliance obligations that began on the CIA’s Effective Date of July 3September 16, 20172016. The Effective Date of this Amendment shall be the date the final signatory signs this Amendment (Amendment Effective Date). B. The undersigned FHS NAHC signatory represents and Xxxxx Xxxxxxxx signatories represent and warrant warrants that they are he is authorized to execute this Amendment. The undersigned OIG signatories represent that they are signing this Amendment in their official capacities and that they are authorized to execute this Amendment. C. This Amendment may be executed in counterparts, each of which constitutes an original and all of which constitute one and the same Amendment. Facsimiles of signatures shall constitute acceptable, binding signatures for purposes of this Amendment. /Xxxxxx Xxxxxx/ _ 2/19/20 XXXXXX XXXXXX XXXXXXX XXXXX DATE President Foundations Chief Executive Officer North American Health SolutionsCare, Inc. /Xxxx X. Xxxxxx/Re/ 05/08/2020_ _ 2/19/20 XXXX X. XXXXXX DATE Counsel for Foundations Health Solutions, Inc. Xxxx Xxxxxxx Xxxxxx Xxxx LLP /Xxxxx Xxxxxxxx/_ _ 2/19/20 XXXXX XXXXXXXX DATE /Xxxx X. Xxxxxx/_ _ 2/19/20 XXXX X. XXXXXX DATE Counsel for Xxxxx Xxxxxxxx Xxxx Xxxxxxx Xxxxxx Xxxx LLP /Xxxx X. Re/ _ 2/28/2020 XXXX X. RE DATE Assistant Inspector General for Legal Affairs Office of Inspector General U.S. Department of Health and Human Services /Xxxxx /Xxxxxx X. Xxxxx/ 3/2/2020 XXXXX Xxxxxx/ _ 5/6/2020 XXXXXX X. XXXXX XXXXXX DATE Senior Counsel Office of Inspector General U.S. Department of Health and Human Services This Appendix contains the requirements relating to the Independent Review Organization (IRO) required by Section III.E III.D of the CIA.

EFFECTIVE AND BINDING AGREEMENT. A. All terms and conditions of the CIA not modified in this Amendment shall remain in effect for the remainder of the five-year period of compliance obligations that began on the CIA’s Effective Date of July 3October 21, 20172016. The Effective Date of this Amendment shall be the date the final signatory signs this Amendment (Amendment Effective Date). B. The undersigned FHS LCCA signatory represents and Xxxxx Xxxxxxxx signatories represent and warrant warrants that they are he is authorized to execute this Amendment. The undersigned OIG signatories represent that they are signing this Amendment in their official capacities and that they are authorized to execute this Amendment. C. This Amendment may be executed in counterparts, each of which constitutes an original and all of which constitute one and the same Amendment. Facsimiles of signatures shall constitute acceptable, binding signatures for purposes of this Amendment. /Xxxxxx Xxxxxx/ _ 2/19/20 XXXXXX XXXXXX /Xxxxxxx X. Xxxxxxx/ 5/15/2020 XXXXXXX X. XXXXXXX DATE President Foundations Health SolutionsChairman and Sole Shareholder Life Care Centers of America, Inc. /Xxxx X. Xxxxxx/Xx/_ _ 2/19/20 XXXX X. XXXXXX DATE Counsel for Foundations Health Solutions, Inc. Xxxx Xxxxxxx Xxxxxx Xxxx LLP /Xxxxx Xxxxxxxx/_ _ 2/19/20 XXXXX XXXXXXXX DATE /Xxxx X. Xxxxxx/_ _ 2/19/20 XXXX X. XXXXXX DATE Counsel for Xxxxx Xxxxxxxx Xxxx Xxxxxxx Xxxxxx Xxxx LLP /Xxxx X. Re/ _ 2/28/2020 06/02/2020 XXXX X. RE DATE Assistant Inspector General for Legal Affairs Office of Inspector General U.S. Department of Health and Human Services /Xxxxx /Xxxxxx X. Xxxxx/ 3/2/2020 XXXXX Xxxxxx/ _ 5/18/20 XXXXXX X. XXXXX XXXXXX DATE Senior Counsel Office of Inspector General U.S. Department of Health and Human Services This Appendix contains the requirements relating to the Independent Review Organization (IRO) required by Section III.E III.D of the CIA.